Variable | Screening study (n = 50) | Evaluation study (n = 204) | |
---|---|---|---|
Gender, n (%) | Â | Â | Â |
 | Male | 22 (44%) | 97 (48%) |
 | Female | 28 (56%) | 107 (52%) |
 | Age, median (Min-Max) | 40.5 (23–59) | 42 (19–66) |
Race, ethnicity, n (%) | Â | Â | |
 | White | 38 (76%) | 201 (98.5%) |
 | Black | 3 (6%) | 0 (0%) |
 | Asian | 8 (16%) | 2 (1%) |
 | Other/unknown | 1 (2%) | 1 (0.5%) |
JCPyV VP1 serology, n (%) | Â | Â | |
 | Positive | 36 (72%) | 156 (57%) |
 | Negative | 14 (28%) | 88 (43%) |
JCPyV Viruria, n (%) | Â | Â | |
 | Positive* | 13 (26%) | 50 (25%) |
 | Negative | 37 (74%) | 154 (75%) |
BKPyV VP1 serology, n (%) | Â | Â | |
 | Positive | n.d. | 178 (88%) |
 | Negative | n.d. | 24 (12%) |
JCPyV_VP2_167-15mer serology, n (%) | Â | Â | |
 | Positive | 32 (64%) | 165 (81%) |
 | Negative | 18 (36%) | 39 (19%) |